Third View Private Wealth, LLC
Source: SEC Form 13F · as of Mar 2026Third View Private Wealth, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $35.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$35.1M
| Company | Shares | Value |
|---|---|---|
| VRTXVERTEX PHARMACEUTICALS INC / MA | 16,901 | $7.5M |
| REGNREGENERON PHARMACEUTICALS, INC. | 7,777 | $6.0M |
| JNJJOHNSON & JOHNSON | 17,947 | $4.4M |
| NVSNovartis AG | 23,830 | $3.6M |
| AZNASTRAZENECA PLC | 18,064 | $3.6M |
| NVONovo Nordisk A/S | 80,438 | $3.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,713 | $1.3M |
| LLYELI LILLY & Co | 1,251 | $1.2M |
| IDXXIDEXX LABORATORIES INC /DE | 1,808 | $1.0M |
| MRKMerck & Co., Inc. | 6,046 | $727K |
| ABBVAbbVie Inc. | 3,051 | $664K |
| AMGNAMGEN INC | 1,414 | $498K |
| PFEPFIZER INC | 16,571 | $465K |
| GMOptec International, Inc. | 5,243 | $391K |
| PMPhilip Morris International Inc | 2,119 | $350K |
| MCKMcKesson Corporation | 378 | $327K |
| NEONeoGenomics Inc. | 14,310 | $106K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.